Search Results

There are 4923 results for: content related to: Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

  1. Trastuzumab containing regimens for early breast cancer

    Intervention Review

    The Cochrane Library

    Lorenzo Moja, Ludovica Tagliabue, Sara Balduzzi, Elena Parmelli, Vanna Pistotti, Valentina Guarneri and Roberto D'Amico

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD006243.pub2

  2. You have free access to this content
    Trastuzumab-containing regimens for metastatic breast cancer

    Intervention Review

    The Cochrane Library

    Sara Balduzzi, Stefania Mantarro, Valentina Guarneri, Ludovica Tagliabue, Vanna Pistotti, Lorenzo Moja and Roberto D'Amico

    Published Online : 12 JUN 2014, DOI: 10.1002/14651858.CD006242.pub2

  3. You have free access to this content
    Adjuvant targeted therapy in early breast cancer


    Volume 115, Issue 6, 15 March 2009, Pages: 1154–1168, John Mackey, Deanna McLeod, Joseph Ragaz, Karen Gelmon, Sunil Verma, Kathleen Pritchard, Kara Laing, Louise Provencher and Lauren F. Charbonneau

    Article first published online : 22 JAN 2009, DOI: 10.1002/cncr.24114

  4. Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

    Clinical Pharmacology & Therapeutics

    Volume 87, Issue 5, May 2010, Pages: 586–592, E C Dijkers, T H Oude Munnink, J G Kosterink, A H Brouwers, P L Jager, J R de Jong, G A van Dongen, C P Schröder, M N Lub-de Hooge and E G de Vries

    Article first published online : 31 MAR 2010, DOI: 10.1038/clpt.2010.12

  5. You have full text access to this Open Access content
    Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer

    Cancer Science

    Volume 102, Issue 1, January 2011, Pages: 1–8, Toru Mukohara

    Article first published online : 6 SEP 2010, DOI: 10.1111/j.1349-7006.2010.01711.x

  6. Comparison of Subcutaneous and Intravenous Administration of Trastuzumab: A Phase I/Ib Trial in Healthy Male Volunteers and Patients With HER2-Positive Breast Cancer

    The Journal of Clinical Pharmacology

    Volume 53, Issue 2, February 2013, Pages: 192–201, Chris Wynne, Vernon Harvey, Christian Schwabe, Devonie Waaka, Christine McIntyre and Beate Bittner

    Article first published online : 22 FEB 2013, DOI: 10.1177/0091270012436560

  7. Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 3, March 2013, Pages: 794–812, Zephania W. Kwong Glover, Lynn Gennaro, Sandeep Yadav, Barthélemy Demeule, Pin Yee Wong and Alavattam Sreedhara

    Article first published online : 5 DEC 2012, DOI: 10.1002/jps.23403

  8. You have full text access to this OnlineOpen article
    [64Cu]-labelled trastuzumab: optimisation of labelling by DOTA and NODAGA conjugation and initial evaluation in mice

    Journal of Labelled Compounds and Radiopharmaceuticals

    Volume 58, Issue 6, 30 May 2015, Pages: 227–233, Christina Schjoeth-Eskesen, Carsten Haagen Nielsen, Søren Heissel, Peter Højrup, Paul Robert Hansen, Nic Gillings and Andreas Kjaer

    Article first published online : 24 APR 2015, DOI: 10.1002/jlcr.3287

  9. You have free access to this content
    Signal transduction of erbB receptors in trastuzumab (Herceptin) sensitive and resistant cell lines: Local stimulation using magnetic microspheres as assessed by quantitative digital microscopy

    Cytometry Part A

    Volume 67A, Issue 2, October 2005, Pages: 161–171, Elza Friedländer, Donna J. Arndt-Jovin, Péter Nagy, Thomas M. Jovin, János Szöllősi and György Vereb

    Article first published online : 14 SEP 2005, DOI: 10.1002/cyto.a.20173

  10. You have full text access to this Open Access content
    Semiquantitative assessment of the microdistribution of fluorescence-labeled monoclonal antibody in small peritoneal disseminations of ovarian cancer

    Cancer Science

    Volume 101, Issue 3, March 2010, Pages: 820–825, Nobuyuki Kosaka, Mikako Ogawa, David S. Paik, Chang H. Paik, Peter L. Choyke and Hisataka Kobayashi

    Article first published online : 31 OCT 2009, DOI: 10.1111/j.1349-7006.2009.01423.x

  11. Impact of Her-2-Targeted Therapy on Overall Survival in Patients With Her-2 Positive Metastatic Breast Cancer

    The Breast Journal

    Volume 19, Issue 2, March/April 2013, Pages: 149–155, Anna S. Berghoff, Zsuzsanna Bago-Horvath, Peter Dubsky, Margaretha Rudas, Ursula Pluschnig, Christoph Wiltschke, Michael Gnant, Guenther G. Steger, Christoph C. Zielinski and Rupert Bartsch

    Article first published online : 27 JAN 2013, DOI: 10.1111/tbj.12070

  12. You have free access to this content
    The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway

    International Journal of Cancer

    Volume 136, Issue 7, 1 April 2015, Pages: 1537–1545, Kojiro Eto, Masaaki Iwatsuki, Masayuki Watanabe, Takatsugu Ishimoto, Satoshi Ida, Yu Imamura, Shiro Iwagami, Yoshifumi Baba, Yasuo Sakamoto, Yuji Miyamoto, Naoya Yoshida and Hideo Baba

    Article first published online : 11 SEP 2014, DOI: 10.1002/ijc.29168

  13. You have free access to this content
    Calpain4 is required for activation of HER2 in breast cancer cells exposed to trastuzumab and its suppression decreases survival and enhances response

    International Journal of Cancer

    Volume 131, Issue 10, 15 November 2012, Pages: 2420–2432, Sucheta Kulkarni, Leya Saju, Carol Farver and Raymond Tubbs

    Article first published online : 28 MAR 2012, DOI: 10.1002/ijc.27510

  14. You have free access to this content
    Systemic treatment of HER2+ metastatic breast cancer: Clinical conundrums and future perspectives

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue S4, June 2014, Pages: 15–25, Richard De Boer, Jane Beith, Jacquie Chirgwin, Sue Chua, Maree Colosimo, Prudence Francis, Michael Green, Ken Pittman, Michelle White, Nicholas Wilcken, Nicholas Zdenkowski and Richard Bell

    Article first published online : 6 MAY 2014, DOI: 10.1111/ajco.12207

  15. You have free access to this content
    Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge

    European Journal of Heart Failure

    Volume 14, Issue 2, February 2012, Pages: 130–137, Carlo G. Tocchetti, Gianluca Ragone, Carmela Coppola, Domenica Rea, Giovanna Piscopo, Stefania Scala, Claudia De Lorenzo, Rosario V. Iaffaioli, Claudio Arra and Nicola Maurea

    Article first published online : 18 FEB 2014, DOI: 10.1093/eurjhf/hfr165

  16. Ablation of Breast Cancer Cells Using Trastuzumab-Functionalized Multi-Walled Carbon Nanotubes and Trastuzumab-Diphtheria Toxin Conjugate

    Chemical Biology & Drug Design

    Volume 83, Issue 3, March 2014, Pages: 259–265, Mojtaba Oraki Kohshour, Sako Mirzaie, Majid Zeinali, Mansour Amin, Mohammad Said Hakhamaneshi, Ali Jalili, Nader Mosaveri and Mostafa Jamalan

    Article first published online : 26 DEC 2013, DOI: 10.1111/cbdd.12244

  17. Primary trastuzumab resistance: new tricks for an old drug

    Annals of the New York Academy of Sciences

    Volume 1210, Issue 1, October 2010, Pages: 53–65, Jason A. Wilken and Nita J. Maihle

    Article first published online : 25 OCT 2010, DOI: 10.1111/j.1749-6632.2010.05782.x

  18. You have free access to this content
    Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer


    Volume 118, Issue 20, 15 October 2012, Pages: 4936–4943, Michelle M. Kim, Shaheenah Dawood, Pamela Allen, Aysegul A. Sahin, Wendy A. Woodward, Benjamin D. Smith, Eric A. Strom, Kelly K. Hunt, Funda Meric-Bernstam, Ana Maria Gonzalez-Angulo and Thomas A. Buchholz

    Article first published online : 17 APR 2012, DOI: 10.1002/cncr.27502

  19. You have free access to this content
    Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer


    Volume 118, Issue 8, 15 April 2012, Pages: 1982–1988, Ana P. Kiess, Heather L. McArthur, Kathleen Mahoney, Sujata Patil, Patrick G. Morris, Alice Ho, Clifford A. Hudis and Beryl McCormick

    Article first published online : 1 SEP 2011, DOI: 10.1002/cncr.26484

  20. You have free access to this content
    HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: An unexpected effect on TRAIL-induced apoptosis

    FEBS Letters

    Volume 579, Issue 19, August 01, 2005, Pages: 4149–4158, Lenka Dubská, Ladislav Anděra and Michael Allen Sheard

    Article first published online : 6 JUL 2005, DOI: 10.1016/j.febslet.2005.06.047